These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37492509)

  • 1. Curcumin-loaded mesoporous silica nanoparticles for drug delivery: synthesis, biological assays and therapeutic potential - a review.
    Iranshahy M; Hanafi-Bojd MY; Aghili SH; Iranshahi M; Nabavi SM; Saberi S; Filosa R; Nezhad IF; Hasanpour M
    RSC Adv; 2023 Jul; 13(32):22250-22267. PubMed ID: 37492509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxymethyl Cellulose-Grafted Mesoporous Silica Hybrid Nanogels for Enhanced Cellular Uptake and Release of Curcumin.
    Tiwari N; Nawale L; Sarkar D; Badiger MV
    Gels; 2017 Feb; 3(1):. PubMed ID: 30920505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Delivery of Cisplatin and Curcumin Using Mesoporous Silica Nanoparticles to Improve their Anticancer Effects.
    Dizaj SM; Bolouri Ebrahimi SS; Jafari S; Basiri A; Yazdani J; Sharifi S; Abdolahinia ED
    Pharm Nanotechnol; 2023; 11(4):364-372. PubMed ID: 36974418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual drug release mechanisms through mesoporous silica nanoparticle/electrospun nanofiber for enhanced anticancer efficiency of curcumin.
    Xu L; Li W; Sadeghi-Soureh S; Amirsaadat S; Pourpirali R; Alijani S
    J Biomed Mater Res A; 2022 Feb; 110(2):316-330. PubMed ID: 34378328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Curcumin-Loaded Mesoporous Silica Nanoparticles on the Head and Neck Cancer Cell Line, HN5.
    Sharifi S; Dalir Abdolahinia E; Ghavimi MA; Dizaj SM; Aschner M; Saso L; Khan H
    Curr Issues Mol Biol; 2022 Oct; 44(11):5247-5259. PubMed ID: 36354669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin-loaded PEGylated mesoporous silica nanoparticles for effective photodynamic therapy.
    Kuang G; Zhang Q; He S; Liu Y
    RSC Adv; 2020 Jun; 10(41):24624-24630. PubMed ID: 35516169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy.
    Wang J; Wang Y; Liu Q; Yang L; Zhu R; Yu C; Wang S
    ACS Appl Mater Interfaces; 2016 Oct; 8(40):26511-26523. PubMed ID: 27619078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
    Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
    Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
    Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The protective effects of curcumin loaded mesoporous silica nanoparticles on rat cardiomyocytes].
    Fu HN; Wu L; Duan LW; Lü SZ
    Yao Xue Xue Bao; 2017 Mar; 52(3):468-73. PubMed ID: 29979866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect.
    Lin J; Cai Q; Tang Y; Xu Y; Wang Q; Li T; Xu H; Wang S; Fan K; Liu Z; Jin Y; Lin D
    Int J Pharm; 2018 Jan; 536(1):272-282. PubMed ID: 29079221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement.
    Hartono SB; Hadisoewignyo L; Yang Y; Meka AK; Antaresti ; Yu C
    Nanotechnology; 2016 Dec; 27(50):505605. PubMed ID: 27875331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-loaded mesoporous silica nanoparticles/nanofiber composites for supporting long-term proliferation and stemness preservation of adipose-derived stem cells.
    Mashayekhi S; Rasoulpoor S; Shabani S; Esmaeilizadeh N; Serati-Nouri H; Sheervalilou R; Pilehvar-Soltanahmadi Y
    Int J Pharm; 2020 Sep; 587():119656. PubMed ID: 32687972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.
    Igaz N; Bélteky P; Kovács D; Papp C; Rónavári A; Szabó D; Gácser A; Kónya Z; Kiricsi M
    Int J Nanomedicine; 2022; 17():3079-3096. PubMed ID: 35859731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Janus nanocarriers for magnetically targeted and hyperthermia-enhanced curcumin therapy of liver cancer.
    Xing H; Wang Z; Shao D; Chang Z; Ge M; Li L; Wu M; Yan Z; Dong W
    RSC Adv; 2018 Aug; 8(53):30448-30454. PubMed ID: 35546840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.